Ozempic’s most common side effects are digestive: nausea, vomiting, diarrhea, and constipation. These affect a significant portion of users, especially in the first few weeks, and typically ease as your body adjusts. But the full picture of side effects goes well beyond an upset stomach, ranging from cosmetic changes to rare but serious risks involving the thyroid, gallbladder, and pancreas.
Nausea and Other Digestive Side Effects
Nausea is the side effect most people experience first. It tends to be mild to moderate and shows up most noticeably during the first four weeks of treatment or right after a dose increase. For most people, it fades after the dose stabilization phase. Vomiting, diarrhea, and constipation follow a similar pattern, appearing early and improving with time.
This is partly why Ozempic uses a gradual dosing schedule. You start at 0.25 mg once per week for four weeks, then move to a maintenance dose of 0.5 mg. If needed, your dose can increase further in four-week intervals, up to a maximum of 2 mg per week. Each bump in dose can temporarily bring digestive symptoms back or make them worse, but the slow ramp gives your body time to adapt.
Eating smaller meals, avoiding high-fat or greasy foods, and staying well hydrated can help take the edge off. The nausea isn’t dangerous on its own, but severe vomiting and diarrhea that go unchecked can lead to dehydration, which has its own consequences (more on that below).
Delayed Stomach Emptying
Ozempic works partly by slowing down how fast your stomach empties, which helps you feel full longer. In some people, this effect goes too far. Gastroparesis, a condition where the stomach takes much longer than normal to move food into the small intestine, has been reported. Symptoms include persistent bloating, upper abdominal discomfort, early fullness after just a few bites, and nausea that doesn’t follow the typical pattern of improving over weeks.
This isn’t just a comfort issue. The American Society of Anesthesiologists now recommends stopping GLP-1 medications like Ozempic at least one week before elective surgery. The concern is that food still sitting in the stomach during anesthesia raises the risk of aspiration, where stomach contents enter the lungs. If you have a scheduled procedure, let your surgical team know you’re taking Ozempic.
Gallbladder Problems
Gallbladder disease is one of the more significant risks. A large systematic review pooling data from 76 randomized controlled trials found that people taking GLP-1 medications like Ozempic had a 37% higher relative risk of developing gallbladder disease compared to those not taking them. This includes both gallstones and gallbladder inflammation.
The connection makes biological sense. Rapid weight loss from any cause increases the risk of gallstones, and Ozempic can produce substantial weight loss relatively quickly. One study of 308 patients found gallstones in about 31% of them, and roughly 60% of those cases were symptomatic. Gallbladder inflammation happens when a stone blocks the duct that drains bile, causing pressure to build. The warning signs are severe pain in the right upper abdomen, fever, and tenderness that gets worse after eating.
Kidney Concerns From Dehydration
Ozempic doesn’t directly damage the kidneys, but it can lead to kidney injury indirectly. When nausea, vomiting, and diarrhea are severe enough to cause dehydration and poor fluid intake over days or weeks, the kidneys don’t get enough blood flow to function properly. Acute kidney injury in Ozempic users is rare, but case reports describe patients arriving with weeks of persistent vomiting and reduced fluid intake before kidney function declined sharply.
The practical takeaway: if you’re unable to keep fluids down for more than a day or two, that’s not a side effect to push through. Persistent vomiting and diarrhea need medical attention before dehydration compounds into something worse.
Muscle Loss During Weight Loss
Not all the weight you lose on Ozempic is fat. A systematic review of six clinical trials involving over 1,500 overweight or obese adults found that while the majority of weight loss came from fat, lean mass losses ranged from nearly 0% to 40% of total weight lost, depending on the trial. Larger studies tended to show more noticeable lean mass reductions.
There’s a nuance here: even when people lost some muscle, their ratio of lean mass to total body weight actually improved because so much fat was lost. Still, losing muscle matters, especially for older adults. Muscle supports metabolism, joint stability, and long-term mobility. Resistance training while taking Ozempic, along with adequate protein intake, is widely recommended to preserve as much lean tissue as possible.
Facial Aging and “Ozempic Face”
Rapid weight loss from Ozempic can cause noticeable changes in facial appearance, sometimes called “Ozempic face.” The fat pads that give the face its fullness, in the cheeks, temples, jawline, and around the lips, shrink. At the same time, the skin doesn’t bounce back quickly because collagen and elastin remodeling can’t keep pace with how fast the underlying fat disappears. The result can be a gaunt, aged look with more prominent nasolabial folds, hollow cheeks, and sagging along the jawline.
This isn’t unique to Ozempic. Any rapid weight loss can do the same thing. But because Ozempic produces significant weight loss in a relatively short window, the cosmetic change can be striking. Some researchers believe the drug may also directly reduce collagen and elastin levels in the skin, compounding the effect beyond what weight loss alone would cause.
The FDA’s Thyroid Warning
Ozempic carries the FDA’s most serious label warning, a boxed warning, for thyroid C-cell tumors. In animal studies, semaglutide caused thyroid tumors at doses comparable to human use, and the risk increased with higher doses and longer treatment. Whether this translates to humans remains unknown. No definitive link to thyroid cancer has been confirmed in people, but the uncertainty itself is why the warning exists.
Because of this risk, Ozempic is completely off-limits for anyone with a personal or family history of medullary thyroid carcinoma or a genetic condition called Multiple Endocrine Neoplasia syndrome type 2. If you notice a lump or mass in your neck, difficulty swallowing, trouble breathing, or persistent hoarseness while taking Ozempic, those are the specific symptoms flagged by the FDA as potential warning signs.
Pancreatitis Risk
Acute pancreatitis, a sudden and painful inflammation of the pancreas, appears on the Ozempic warning label, but the actual risk in clinical trials has been very low. Major cardiovascular outcomes trials like SUSTAIN-6 and LEADER found no significant difference in confirmed pancreatitis between semaglutide users and placebo groups. The REWIND trial reported fewer than 0.1% of cases per year. A meta-analysis found no significant increase in pancreatitis or pancreatic cancer with GLP-1 medications overall.
That said, pancreatitis is serious when it does occur. Severe, persistent abdominal pain that radiates to the back, especially with vomiting, is the hallmark symptom and warrants immediate evaluation.
Who Should Not Take Ozempic
Beyond the thyroid restrictions, Ozempic is contraindicated for anyone with a known allergy to semaglutide or any of its inactive ingredients. People with a history of pancreatitis should discuss their risk carefully, and those with existing gastroparesis or severe gastrointestinal disease may find the digestive side effects intolerable or dangerous. If you have chronic kidney disease, the dehydration risk from GI side effects requires closer monitoring.